Callan JMB Announces First Quarter 2025 Financial Results and Provides Business Update

Core Insights - Callan JMB Inc. completed its Initial Public Offering (IPO) on February 6, 2025, at a price of $4.00 per share, raising approximately $5.7 million in gross proceeds, including a partial exercise of the over-allotment option [1][5]. Business Highlights - Callan JMB is positioning itself as a leading provider of advanced logistics and fulfillment services in high-growth sectors, including GLP-1 pharmaceutical transportation and specialized compounding pharmacy logistics [2]. - The company is expanding its emergency preparedness and response operations, targeting untapped metropolitan areas and states, with a new Senior Vice President appointed to accelerate this growth [2]. - Callan JMB has been requested by the Texas Department of Health and Human Services to assist with a measles outbreak response and has renewed its arrangement with the Texas Department of State Health Services [5]. Financial Highlights - For the first quarter of 2025, Callan JMB reported revenue of $1.45 million, a decrease from $1.79 million in the same quarter of the previous year, attributed to reduced demand for emergency preparedness services [5][13]. - The cost of revenue for the first quarter was $0.8 million, resulting in a gross profit of $0.6 million and a gross profit margin of 42.5% [5][13]. - Selling, general, and administrative (SG&A) expenses for the first quarter were $1.9 million, reflecting an increase due to consulting fees related to the IPO and new senior staff hires [5][13]. - The company reported a net loss of $1.24 million for the first quarter of 2025, compared to a net loss of $0.08 million in the same quarter of the previous year [11][14]. Balance Sheet Overview - As of March 31, 2025, Callan JMB's total assets were approximately $8.46 million, with current assets of $6.8 million, including cash of $5.22 million [10][12]. - Total liabilities stood at approximately $1.65 million, with current liabilities of $1.05 million [12]. - Stockholders' equity was reported at approximately $6.81 million, reflecting an increase from the previous period [12].